Search
Filter Results
Displaying 461–470 of 830 for “retinal diseases”
-
The Foundation encourages individuals and teams from all scientific disciplines that have ideas geared toward eliminating inherited retinal degenerative diseases to apply to a grant or award program. Individuals from underrepresented racial, ethnic, and gender groups, as well as individuals with disabilities, are always encouraged to apply.
-
Jun 1, 2023
Coave Reports Encouraging Phase 1/2 Clinical Trial Results for PDE6B Gene Therapy
The company is expanding the trial to enroll younger patients with less advanced disease
-
Apr 21, 2023
Clinical trial participants with advanced vision loss from RP were able to identify fruits and vegetables
-
Feb 15, 2022
ProQR’s Phase 2/3 Clinical Trial for LCA10 RNA Therapy Doesn’t Meet Endpoints
The emerging treatment had shown encouraging results in a Phase ½ clinical trial
-
Feb 8, 2022
AGTC Plans Further Clinical Development of Achromatopsia (CNGB3) Gene Therapy
Interim results for pediatric patients with CNGB3 mutations were encouraging
-
A Chapter is the collective group of volunteers and leaders coming together to fulfill the mission of the Foundation Fighting Blindness. They do this by hosting Chapter meetings. Each meeting will provide educational updates, provide resources in the community, and identify, cultivate, and generate revenue.
-
Oct 29, 2020
Novartis Acquires Vedere Bio, a Novel Optogenetics AAV Gene Therapy Company
-
Oct 21, 2020
SparingVision Raises €44.5 Million for Gene-Independent RP Therapy
The company is planning a clinical trial for its emerging neuroprotective treatment in 2021
-
Apr 1, 2020
Interim Results Released for USH2A RNA Therapy Clinical Trial
Suggestions of efficacy observed in 25 percent of participants receiving the treatment
-
At the Foundation Fighting Blindness, our employees are true beacons of hope as they are committed to our urgent mission to drive the research that will provide preventions, treatments and cures for people affected by retinitis pigmentosa, age-related macular degeneration, Usher syndrome and the entire spectrum of retinal degenerative diseases.